ABSORPTION, EXCRETION, AND METABOLISM OF HB419-14C AFTER INTRAVENOUS AND ORAL APPLICATION TO HUMANS

被引：0
|
作者：
RUPP, W
CHRIST, O
HEPTNER, W
机构：
来源：
ARZNEIMITTEL-FORSCHUNG | 1969年 / 19卷 / 8A期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：1428 / &
相关论文
共 50 条
  • [21] ABSORPTION, DISTRIBUTION AND EXCRETION OF RADIOACTIVITY AFTER A SINGLE INTRAVENOUS OR ORAL-ADMINISTRATION OF [C-14] GLUCOSAMINE TO THE RAT
    SETNIKAR, I
    GIACHETTI, C
    ZANOLO, G
    PHARMATHERAPEUTICA, 1984, 3 (08) : 538 - 550
  • [22] A Novel Double-Tracer Technique to Characterize Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]Tofogliflozin After Oral Administration and Concomitant Intravenous Microdose Administration of [13C]Tofogliflozin in Humans
    Schwab, Dietmar
    Portron, Agnes
    Backholer, Zoe
    Lausecker, Berthold
    Kawashima, Kosuke
    CLINICAL PHARMACOKINETICS, 2013, 52 (06) : 463 - 473
  • [23] A Novel Double-Tracer Technique to Characterize Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]Tofogliflozin After Oral Administration and Concomitant Intravenous Microdose Administration of [13C]Tofogliflozin in Humans
    Dietmar Schwab
    Agnes Portron
    Zoe Backholer
    Berthold Lausecker
    Kosuke Kawashima
    Clinical Pharmacokinetics, 2013, 52 : 463 - 473
  • [24] Absorption, metabolism and excretion after oral administration of a new Ca antagonist, C-14-benidipine hydrochloride to man
    Kobayashi, H
    Kobayashi, S
    Dalrymple, PD
    Wood, SG
    Chasseaud, LF
    XENOBIOTICA, 1997, 27 (06) : 597 - 608
  • [25] Pharmacokinetics and metabolism of [14C]eplerenone after oral administration to humans
    Cook, CS
    Berry, LM
    Bible, RH
    Hribar, JD
    Hajdu, E
    Liu, NW
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (11) : 1448 - 1455
  • [26] BILIARY-EXCRETION OF INTRAVENOUS [C-14] OMEPRAZOLE IN HUMANS
    LIND, T
    ANDERSSON, T
    SKANBERG, I
    OLBE, L
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (05) : 504 - 508
  • [27] ABSORPTION DISTRIBUTION METABOLISM AND EXCRETION OF ORAL [14C]-IBREXAFUNGERP IN HEALTHY MALE SUBJECTS
    Azie, N.
    Angulo, D.
    Evans, P.
    Murphy, G.
    Ghahramani, P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S12 - S12
  • [28] ABSORPTION, METABOLISM, AND EXCRETION OF [14C]AXELOPRAN, A PERIPHERALLY-RESTRICTED NEUTRAL μ-OPIOID RECEPTOR ANTAGONIST, AFTER ORAL AND INTRAVENOUS ADMINISTRATION TO HEALTHY HUMAN VOLUNTEERS
    Bolleddula, Jayaprakasam
    Washington, Carla
    Colson, Pierre-Jean
    Amrite, Aniruddha
    Vickery, Ross
    Worboys, Philip
    Bourdet, David L.
    DRUG METABOLISM REVIEWS, 2015, 47 : 199 - 199
  • [29] Absorption, metabolism and excretion of [14C]gemigliptin, a novel dipeptidyl peptidase 4 inhibitor, in humans
    Kim, Namtae
    Patrick, Lorna
    Mair, Stuart
    Stevens, Lloyd
    Ford, Gill
    Birks, Vicky
    Lee, Sung-Hack
    XENOBIOTICA, 2014, 44 (06) : 522 - 530
  • [30] ABSORPTION, METABOLISM AND EXCRETION OF [14C]-GEMIGLIPTIN, A NOVEL DIPEPTIDYL PEPTIDASE 4 INHIBITOR, IN HUMANS
    Lee, Sung-Hack
    Kim, Namtae
    Ford, Gill
    Wood, Stuart
    Mair, Stuart
    Walker, Helen
    Shaw, Iain
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S78 - S78
12345